1. Absorption, metabolism, and excretion of taselisib (GDC-0032), a PI3K inhibitor, in rats, dogs, and humans. Issue 1 (January 2017) Authors: Ma, Shuguang; Salphati, Laurent; Srikumar, Srikumar; Takahashi, Ryan; Ding, Xiao; Pang, Jodie; Wang, Bing; Remarchuk, Travis; Hsu, Jerry; Hop, Cornelis (Marcel); Ware, Joseph A.; Khojasteh, S. Cyrus Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017)Supplement Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗